TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Problems

A review of evidence-based management of uterine fibroids

Key Statistics

  • ~30% — Lifetime prevalence of fibroids
  • 1:4 — Women with fibroids who are symptomatic
  • 36% — Leiomyoma size reduction, GnRH analogue (12WK)

Don't-miss facts

  1. Only 1 in 4 women with fibroids are symptomatic; lifetime prevalence ~30%; median growth 9%/6 months supports expectant management if asymptomatic

  2. GnRH analogue preoperative use capped at 6 months; ↓leiomyoma size by 36% at 12 weeks but blurs myomectomy dissection plane

  3. PEARL I (UA): >90% ↓bleeding, fibroid volume change 41% vs 18%; PEARL II noninferior to leuprolide

  4. UAE mortality 1:10,000 vs hysterectomy 3:10,000; but ~5-fold ↑reintervention risk vs surgery (23% at 5 years, HOPEFUL)

  5. MRgFUS: NICE – research/audit use only; not for women wanting to preserve fertility; 21–28% need reintervention

  6. ESGE/FIGO submucous fibroid grading (0/I/II): Grade 0/1 – easy hysteroscopic resection; Grade 2 (≥50% intramural) – depends on myometrium–serosa thickness

  7. Resectoscopic slicing = gold standard for Grade 0 hysteroscopic myomectomy; no single proven technique for Grades 1–2

  8. Fibroids cause one-third of US hysterectomies; laparoscopic myomectomy preferred if fertility desired

Evidence tiers at a glance

Good evidence: medical Rx, UAE, MRgFUS for symptom relief

Needs more research: fertility safety of UAE/MRgFUS; SPRM long-term effects

Abbreviation Key

  • UAE — uterine artery embolisation
  • STEPW — size, topography, extension, penetration, lateral wall (classification)
  • MRgFUS — magnetic resonance imaging-guided focused ultrasound
  • NICE — National Institute for Health and Care Excellence
  • GnRH — gonadotrophin-releasing hormone
  • FDA — Food and Drug Administration
  • SPRM — selective progesterone-receptor modulator
  • OR — odds ratio
  • UA — ulipristal acetate
  • CI — confidence interval
  • LNG-IUS — levonorgestrel intrauterine system
  • PICO — participants, intervention, comparison, outcome
  • ESGE — European Society of Gynaecological Endoscopy
  • CASP — Critical Appraisal Skills Programme
  • FIGO — International Federation of Gynaecology and Obstetrics

Source: Younas K, Hadoura E, Majoko F, Bunkheila A. A review of evidence-based management of uterine fibroids. The Obstetrician & Gynaecologist 2016;18:33–42. doi:10.1111/tog.12223

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free